饮食预防肝癌的作用研究进展

doi:10.3969/j.issn.1672-5069.2014.05.005

Abstract

Wang Ge, Jiang Mei. Consumption of healthy foods and beverages reduces risk for hepatocellular carcinoma[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(5): 463-465.

[1] El-Serag HB. Hepatocellular carcinoma. N Engl J Med, 2011,365（12）:1118-1127.
[2] Cross AJ,Freedman ND,Ren J. Meat consumption and risk of esophageal and gastric cancer in a large prospective study. Am J Gastroenterol,2011,106（3）:432-442.
[3] Larsson SC,Wolk A. Red and processed meat consumption and risk of pancreatic cancer:meta-analysis of prospective studies. Br J Cancer,2012,106（3）:603-607.
[4] Yang WS,Wong MY,Vogtmann E. Meat consumption and risk of lung cancer:evidence from observational studies. Ann Oncol,2012,23（12）:3163-3170.
[5] Kanazir M,Boricic I,Delic D. Risk factors for hepatocellular carcinoma:a case-control study in Belgrade （Serbia）. Tumori, 2010,96（6）:911-917.
[6] Abid Z,Cross AJ,Sinha R. Meat,dairy,and cancer. Am J Clin Nutr,doi:10.3945/ajcn. 113.071597.
[7] Tasevska N,Sinha R. A prospective study of meat, cooking methods,meat mutagens,heme iron,and lung cancer risks. Am J Clin Nutr,2009,89:1884-1894.
[8] Freedman ND,Cross AJ,McGlynn KA. Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIHAARP cohort. J Natl Cancer Inst,2010,102（17）:1354-1365.
[9] Fedirko V,Trichopolou A,Bamia C. Consumption of fish and meats and risk of hepatocellular carcinoma:the European Prospective Investigation into Cancer and Nutrition （EPIC）. Ann Oncol,2013,24（8）:2166-2173.
[10] Luo J,Yang Y. Systematic review with meta-analysis:meat consumption and the risk of hepatocellular carcinoma. Aliment Pharmacol Ther,2014,39（9）:913-922.
[11] Fauser JK,Prisciandaro LD. Fatty acids as potential adjunctive colorectal chemotherapeutic agents. Cancer Biol Ther,2011,11（8）:724-731.
[12] Huang C,Ding G,Gu C. Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1ato promote hepatocellular carcinoma invasiveness. Clin Cancer Res,2012,18（11）:3042-3053.
[13] Hou Y,Zhuang W,Hu W. Consumption of large amounts of allium vegetables reduces risk for gastric cancer in a meta-analysis. Gastroenterology,2011,141（1）:80-89.
[14] Kurahashi N,Inoue M. JPHC Study Group:Vegetable,fruit and antioxidant nutrient consumption and subsequent risk of hepatocellular carcinoma:a prospective cohort study in Japan. Br J Cancer,2009,100（1）:181-184.
[15] Huang CS,Liao JW,Hu ML. Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic mice. J Nutr,2008,138（3）:538-543.
[16] Nishion H. Phyotchemicals in hepatocellular cancer prevention.Nutr Cancer,2009,61（6）:789-791.
[17] Piljac-Zegarac J,Samec D,Piljac A. Antioxidant properties of extracts of wild medicinal mushroom species from Croatia. Int J Med Mushrooms,2011,13（3）:257-263.
[18] Shah SK,Peter A. An evidence-based review of a lentinula edodes mushroom extract as complementary therapy in the surgical oncology patient. JPEN,2011,35（4）:449-458.
[19] Zhang W,Xiang YB. Vegetable-based dietary pattern and liver cancer risk:Results from the Shanghai Women,s and Men,s Health Studies. Cancer Sci,2013,104（10）:1353-1361.
[20] Bishayee A,Politis T,Darvesh AS. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat Rev,2010,36（1）:43-53.
[21] Howells LM,Berry DP,Elliott PJ. Phase I randomized, double-blind pilot study of micronized resveratrol（SRT501） in patients with hepatic metastases-safety,pharmacokinetics,and pharmacodynamics.Cancer Prev Res （Phila）,2011,4（9）:1419-1425.
[22] Liu Y,Liu M,Li B. Fresh raspberry phytochemical extract inhibits hepatic lesion in a Wistar rat model. Nutr Metab （Lond）,2010,7:84.
[23] Morii H,Kuboyama A,Nakashima T. Effects of instant coffee consumption on oxidative DNA damage,DNA repair,and redox system in mouse liver. J Food Sci,2009,74（6）:H155-161.
[24] Bravi F,Bosetti C,Tavani A. Coffee drinking and hepatocellular carcinoma risk:a meta-analysis. Hepatology,2007,46（2）:430-435.
[25] Johnson S,Koh WP,Wang R. Coffee consumption and reduced risk of hepatocellular carcinoma:findings from the Singapore Chinese Health Study. Cancer Causes Control,2011,22（3）:503-510.
[26] Masterjohn C,Bruno RS. The therapeutic potential of green tea in non-alcoholic fatty liver disease. Nutr Rev,2012,70（1）:41-56.
[27] Li Y,Chang SC,Goldstein BY. Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population. Cancer Epidemiol,2011,35（4）:362-368.
[28] Fon Sing M,Yang WS,Gao S. Epidemiological studies of the association between tea drinking and primary liver cancer:a meta-analysis. Eur J Cancer Prev,2011,20（3）:157-165.

Consumption of healthy foods and beverages reduces risk for hepatocellular carcinoma

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[2]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[3]	Zhu Jun, Ding Ying, Wang Shiqing, et al. Peripheral blood Th22 cells and plasma interleukin-22 level changes in patients with hepatocellular carcinoma after hepatectomy and administration of ulinastatin [J]. Journal of Practical Hepatology, 2019, 22(5): 720-723.
[4]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[5]	Qiao Zhizhong. Value of contrast-enhanced ultrasonography in differential diagnosis of patients with focal nodular hyperplasia and hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 421-424.
[6]	Zhu Guangxi，Wen Liangzhi，Chen Dongfeng. Pathogenesis of non-alcoholic fatty liver disease-related hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 453-456.
[7]	Liu Liwei, Zhao Xinyan. Clinicopathological features of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 160-163.
[8]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[9]	Xing Diankui, Cheng Jing. Clinical value of ¹⁸F-FDG PET/CT scan in patients with hepatocellular carcinoma and hepatic microvascular invasion [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 252-254.
[10]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.
[11]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[12]	Wang Zhaoxia, Guan Ke, Fu Sanxian, Wang Huijie. Early administration of enteral nutrition in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 272-275.
[13]	Zhao Xitai, Nie Qinghe. Serum microRNA in diagnosis of patients with hepatocellular carcinoma and methodological progress [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 297-300.
[14]	Fan Jiangao.. Highlights of Journal of Practical Hepatology in 2018 [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 1-3.
[15]	Yusup Tursun, Zhao Yanxia.. Establishment of low-dose diethylnitrosamine-induced liver fibrosis model in rats [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 33-36.